Structurally Defined αMHC-II Nanobody-Drug Conjugates: A Therapeutic and Imaging System for B-Cell Lymphoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structurally Defined αMHC-II Nanobody-Drug Conjugates: A Therapeutic and Imaging System for B-Cell Lymphoma
Authors
Keywords
-
Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 55, Issue 7, Pages 2416-2420
Publisher
Wiley
Online
2016-01-15
DOI
10.1002/anie.201509432
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fluorophore-Conjugated Holliday Junctions for Generating Super-Bright Antibodies and Antibody Fragments
- (2015) Zeyang Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development
- (2015) Paresh Agarwal et al. BIOCONJUGATE CHEMISTRY
- Antibody fragment-conjugated polymeric micelles incorporating platinum drugs for targeted therapy of pancreatic cancer
- (2015) Jooyeon Ahn et al. BIOMATERIALS
- Graphene Oxide Nanosheets Modified with Single-Domain Antibodies for Rapid and Efficient Capture of Cells
- (2015) Guan-Yu Chen et al. CHEMISTRY-A EUROPEAN JOURNAL
- In vivo imaging with antibodies and engineered fragments
- (2015) Amanda C. Freise et al. MOLECULAR IMMUNOLOGY
- Nanobody-based cancer therapy of solid tumors
- (2015) Marta Kijanka et al. Nanomedicine
- Noninvasive imaging of immune responses
- (2015) Mohammad Rashidian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency
- (2015) Roger R. Beerli et al. PLoS One
- A CXCR4-Targeted Site-Specific Antibody-Drug Conjugate
- (2014) Sumith A. Kularatne et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Preparation of Well-Defined Antibody-Drug Conjugates through Glycan Remodeling and Strain-Promoted Azide-Alkyne Cycloadditions
- (2014) Xiuru Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Site-Specific Labeling of Cysteine-Tagged Camelid Single-Domain Antibody-Fragments for Use in Molecular Imaging
- (2014) Sam Massa et al. BIOCONJUGATE CHEMISTRY
- Chemoenzymatic Fc Glycosylation via Engineered Aldehyde Tags
- (2014) Elizabeth L. Smith et al. BIOCONJUGATE CHEMISTRY
- A Chemically Defined Trifunctional Antibody-Cytokine-Drug Conjugate with Potent Antitumor Activity
- (2014) T. List et al. MOLECULAR CANCER THERAPEUTICS
- Nanobody–photosensitizer conjugates for targeted photodynamic therapy
- (2014) Raimond Heukers et al. Nanomedicine-Nanotechnology Biology and Medicine
- Metabolic Engineering of Monoclonal Antibody Carbohydrates for Antibody–Drug Conjugation
- (2013) Nicole M. Okeley et al. BIOCONJUGATE CHEMISTRY
- Camelid single-domain antibody-fragment engineering for (pre)clinicalin vivomolecular imaging applications: adjusting the bullet to its target
- (2013) Jens De Vos et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Site-specific N-terminal labeling of proteins using sortase-mediated reactions
- (2013) Christopher S Theile et al. Nature Protocols
- Site-specific C-terminal and internal loop labeling of proteins using sortase-mediated reactions
- (2013) Carla P Guimaraes et al. Nature Protocols
- Maturing antibody–drug conjugate pipeline hits 30
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Design optimization and characterization of Her2/neu-targeted immunotoxins: comparative in vitro and in vivo efficacy studies
- (2013) Y Cao et al. ONCOGENE
- Immunocytokines: a novel class of potent armed antibodies
- (2012) Nadine Pasche et al. DRUG DISCOVERY TODAY
- Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
- (2012) Ben-Quan Shen et al. NATURE BIOTECHNOLOGY
- Preparation of unnatural N-to-N and C-to-C protein fusions
- (2012) Martin D. Witte et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Pictet-Spengler ligation for protein chemical modification
- (2012) P. Agarwal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
- (2012) J. Y. Axup et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combined MUC1-specific nanobody-tagged PEG-polyethylenimine polyplex targeting and transcriptional targeting of tBid transgene for directed killing of MUC1 over-expressing tumour cells
- (2011) Elham Sadeqzadeh et al. JOURNAL OF CONTROLLED RELEASE
- Malignant B Cells Skew the Balance of Regulatory T Cells and TH17 Cells in B-Cell Non-Hodgkin's Lymphoma
- (2009) Zhi-Zhang Yang et al. CANCER RESEARCH
- Anti-CD30 diabody-drug conjugates with potent antitumor activity
- (2008) K. M. Kim et al. MOLECULAR CANCER THERAPEUTICS
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now